IMARC Group has recently released a new research study “Pressure Ulcers Treatment Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
What are the growth prospects of the Pressure Ulcers Treatment Industry?
The global pressure ulcers treatment marketsize reached US$ 4.75 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 6.58 Billion by 2027, exhibiting a growth rate (CAGR) of 5.40% during 2022-2027.
What is a Pressure Ulcers Treatment Market ?
Pressure ulcers, also called bedsores, are degenerative skin and underlying tissue injuries caused by prolonged pressure and shearing forces on the skin. They generally affect the bony and muscle areas of the body, including the back, buttocks, tailbone, heels, elbow, shoulder, ankles, etc.
Request For Sample Report: https://www.imarcgroup.com/pressure-ulcers-treatment-market/requestsample
Pressure ulcers lead to morbidity and mortality, especially among individuals with impaired sensation, poor nutrition, comorbidities, prolonged immobility, etc. They are cured by appropriate preventive measures and medications that aid in preventing deep craters with exposed muscle and bone.
Pressure ulcer treatment involves removing necrotic tissue, reducing pressure on the affected skin, caring for wounds, controlling pain, maintaining good nutrition, creating a moist environment for wound healing, etc.
It also involves wound cleansing with normal saline and appropriate dressings for the infected area. Early identification and treatment of these ulcers minimize the risk of complications, such as bone and joint infections, cellulitis, sepsis, cancer, etc.
Covid-19 Impact:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
What are the major market drivers in the Pressure Ulcers Treatment Market:
The expanding geriatric population across countries is primarily augmenting the pressure ulcers treatment market. Furthermore, the elevating prevalence of obesity and chronic medical diseases is acting as another significant growth-inducing factor.
Apart from this, the growing consumer awareness towards the early diagnosis of bedsores and the easy availability of treatment are positively influencing the global market.
Moreover, the increasing number of hospitals, clinics, pharmacies, drug stores, etc., and the introduction of technological advancements in the healthcare sector are also bolstering the market growth.
Besides this, the rising focus of key market players on the formulation of novel wound care products is expected to fuel the pressure ulcers treatment market in the coming years.
| Pressure Ulcers Treatment Market Report Scope | |
| Report Coverage | Details |
| Market size value in 2021 | US$ 4.75 Billion |
| Market forecast in 2027 | US$ 6.58 Billion |
| Growth Rate | CAGR of 5.40% from 2022 to 2027 |
| Base year for estimation | 2021 |
| Historical data | 2016-2021 |
| Forecast period | 2022-2027 |
| Report coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, And Trends |
| Segments covered | Ulcer Type, Product Type And End User |
| Regional scope | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Key companies profiled | 3M Company, Arjo AB, B. Braun Melsungen AG (B. Braun Holding GmbH & Co. KG), Cardinal Health Inc., Coloplast A/S, Hill-Rom Holdings Inc. (Baxter International Inc.), Invacare Corporation, Mölnlycke Health Care AB, Smith & Nephew plc, Span America (UTi Worldwide Inc.), Stiegelmeyer GmbH & Co. KG and Stryker Corporation. |
| Market Dynamics | Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
| Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Report Segmentation:
The report has been segmented the market into following categories:
Breakup by Type:
- Artificial Saliva/Saliva Substitutes
- Salivary Stimulants
Breakup by Drug Type:
- OTC
- Prescription
Breakup by Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Geography:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
List of Major Key Players:
3M Company
Arjo AB
- Braun Melsungen AG (B. Braun Holding GmbH & Co. KG)
Cardinal Health Inc.
Coloplast A/S
Hill-Rom Holdings Inc
(Baxter International Inc.)
Invacare Corporation
Mölnlycke Health Care AB
Smith & Nephew plc
Span America (UTi Worldwide Inc.)
Stiegelmeyer GmbH & Co. KG
and Stryker Corporation.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
